Skip to main content

4 articles related to "Extended Interval Dosing"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Brief Research Report

Published on 25 Mar 2021

Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study

in Multiple Sclerosis and Neuroimmunology

Javier Riancho
Sonia Setien
Jose Ramón Sánchez de la Torre
Marta Torres-Barquin
Mercedes Misiego
José Luis Pérez
Tamara Castillo-Triviño
Cristina Menéndez-García
Manuel Delgado-Alvarado

Frontiers in Immunology

doi 10.3389/fimmu.2021.614715

7,466 views
24 citations

Case Report

Published on 20 Sep 2024

Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1

in Pediatric Pulmonology

Charles Nakar
Heather McDaniel
Joseph M. Parker
Karen Thibaudeau
Neelam Thukral
Amy D. Shapiro

Frontiers in Pediatrics

doi 10.3389/fped.2024.1465166

2,129 views
3 citations

Brief Research Report

Published on 01 Feb 2023

Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study

in Multiple Sclerosis and Neuroimmunology

Pilar Santiago-Setien
Cristina Barquín-Rego
Paula Hernández-Martínez
María Ezquerra-Marigomez
Marta Torres-Barquin
Cristina Menéndez-Garcia
Fernando Uriarte
Yésica Jiménez-López
Mercedes Misiego
Jose Ramón Sánchez de la Torre

Frontiers in Immunology

doi 10.3389/fimmu.2023.1086028

8,907 views
6 citations

Original Research

Published on 09 Dec 2021

Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice

in Molecular Innate Immunity

Ola Kamala
Talat H. Malik
Thomas M. Hallam
Thomas E. Cox
Yi Yang
Falguni Vyas
Saimir Luli
Chloe Connelly
Beth Gibson
Kate Smith-Jackson

Frontiers in Immunology

doi 10.3389/fimmu.2021.752916

7,480 views
11 citations